GSK buys out Novartis in $13 billion consumer healthcare shake-up

ZURICH (Reuters) – GlaxoSmithKline is buying Novartis out of their consumer healthcare joint venture for $13 billion, taking full control of products including Sensodyne toothpaste, Panadol headache tablets, muscle gel Voltaren, and Nicotinell patches.